Cargando…
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) of the phenylacetic acid class with anti-inflammatory, analgesic, and antipyretic properties. Contrary to the action of many traditional NSAIDs, diclofenac inhibits cyclooxygenase (COX)-2 enzyme with greater potency than it does COX-1. Simi...
Autores principales: | Altman, Roy, Bosch, Bill, Brune, Kay, Patrignani, Paola, Young, Clarence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445819/ https://www.ncbi.nlm.nih.gov/pubmed/25963327 http://dx.doi.org/10.1007/s40265-015-0392-z |
Ejemplares similares
-
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X Receptor
por: Schmidt, Jurema, et al.
Publicado: (2015) -
Crystal structure of a new hydrate form of the NSAID sodium diclofenac
por: Angel Nieto, Ismael, et al.
Publicado: (2020) -
An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac
por: Selvaraj, Saravanakumar, et al.
Publicado: (2020) -
Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
por: Renner, Kathrin, et al.
Publicado: (2018) -
Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations
por: Stuve, Olaf, et al.
Publicado: (2020)